← Return to Optimal Duration of Hormone Therapy

Discussion
oldgreenpaint avatar

Optimal Duration of Hormone Therapy

Prostate Cancer | Last Active: 10 hours ago | Replies (66)

Comment receiving replies
Profile picture for surftohealth88 @surftohealth88

@jeffmarc

Jeff - do you know if Madicare covers Nubeqa no matter what ?
We listened to your advise that you gave another patient couple of months back and "demanded" Nubeqa and we got a prescription. We personally can not THANK YOU enough since we would not know how to navigate the system or what to ask for. 🙏💗
Now we are waiting to see if it will pass Kerberos keepers in insurance 😑. MO thought that there should be no problems, but I am wondering and keeping my fingers crossed.

Jump to this post


Replies to "@jeffmarc Jeff - do you know if Madicare covers Nubeqa no matter what ? We listened..."

@surftohealth88
There is one issue. It is not FDA approved for mCRPC. So people with metastasis, and that are castrate resistant may have a little bit of a problem. I know I didn’t have a problem, but I know a lot of people over at ancan.org We’re able to get it prescribed, even though they were in this situation. It’s sort of crazy that Non-metastatic nmCRPC Are approved for it. I suspect it comes down to the fact that they don’t want to pay for a clinical trial to prove something they know is just a given.

It would be interesting to hear what the final result is of this request.

If you are castrate sensitive, which I suspect your husband is, it shouldn’t be a problem

@surftohealth88 If the MO said no problem than it should be approved. The key is the request for approval should medically exclude Zytiga as an alternative. The approvers are just looking at the $$$ and Erleada, Nubeqa, Xtandi are all so similar in cost insurance does not care. But a year of Zytiga is $100K less than any of the 3 ARSIs. For switches, PSA is now rising even with Zytiga is gold; then come heart issues, etc.